These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8917645)

  • 1. Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
    Abraham TW; Kalman TI; McIntee EJ; Wagner CR
    J Med Chem; 1996 Nov; 39(23):4569-75. PubMed ID: 8917645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
    Freel Meyers CL; Hong L; Joswig C; Borch RF
    J Med Chem; 2000 Nov; 43(22):4313-8. PubMed ID: 11063625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs.
    Tobias SC; Borch RF
    J Med Chem; 2001 Dec; 44(25):4475-80. PubMed ID: 11728193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug.
    Tobias SC; Borch RF
    Mol Pharm; 2004; 1(2):112-6. PubMed ID: 15832507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid phosphoramidate nucleosides: potential ADEPT/GDEPT substrates.
    McIntee EJ; Wagner CR
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2803-5. PubMed ID: 11597404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
    Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
    Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.
    Kanzawa F; Hoshi A; Kuretani K; Saneyoshi M; Kawaguchi T
    Cancer Chemother Pharmacol; 1981; 6(1):19-23. PubMed ID: 6456083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
    Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
    Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergism of 6-mercaptopurine plus cytosine arabinoside followed by PEG-asparaginase in human leukemia cell lines (CCRF/CEM/0 and (CCRF/CEM/ara-C/7A) is due to increased cellular apoptosis.
    Nandy P; Periclou AP; Avramis VI
    Anticancer Res; 1998; 18(2A):727-37. PubMed ID: 9615712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
    Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells.
    Xu YZ; Plunkett W
    J Biol Chem; 1993 Oct; 268(30):22363-8. PubMed ID: 8226747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogs.
    Fries KM; Joswig C; Borch RF
    J Med Chem; 1995 Jul; 38(14):2672-80. PubMed ID: 7629806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
    FitzGerald GB; Ratliff J; Wick MM
    Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.